What does UNIVERSAL RENAL CARE do?

UNIVERSAL RENAL CARE is registered with the CBE as active in: Activiteiten van holdings. Public Limited, started on 16 December 2019, 1 establishment.

What is the address of UNIVERSAL RENAL CARE?

The registered office of UNIVERSAL RENAL CARE is located at Blokhuisstraat 42, 2800 Mechelen.

Is UNIVERSAL RENAL CARE still active?

Yes. According to the CBE (30 October 2026) UNIVERSAL RENAL CARE is active, legal situation “Normale toestand”, started on 16 December 2019.

Is UNIVERSAL RENAL CARE registered on Peppol?

Yes, UNIVERSAL RENAL CARE is registered on the Peppol network with ID 0208:0739651526.

What is the enterprise number of UNIVERSAL RENAL CARE?

The enterprise number of UNIVERSAL RENAL CARE is BE0739651526.

When was UNIVERSAL RENAL CARE founded?

UNIVERSAL RENAL CARE was founded on 16 December 2019.

Who are the directors of UNIVERSAL RENAL CARE?

According to the 2025 annual accounts, the directors of UNIVERSAL RENAL CARE are: Goichi Miyazumi, Hiroki FURUKAWA, Serge Ivonne K KEMPS.

Is UNIVERSAL RENAL CARE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 December 2019; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did UNIVERSAL RENAL CARE make in 2025?

UNIVERSAL RENAL CARE recorded a loss after taxes of € 6,046 in financial year 2025.

What is the revenue of UNIVERSAL RENAL CARE?

In its most recent annual accounts (2025), UNIVERSAL RENAL CARE reported revenue of € 18,398.

How much does an employee at UNIVERSAL RENAL CARE earn?

The average wage cost per full-time employee at UNIVERSAL RENAL CARE was € 271,900 in 2023: staff costs of € 271,867 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

Does UNIVERSAL RENAL CARE have a website?

Yes, UNIVERSAL RENAL CARE has a website at nipro-group.com.

UNIVERSAL RENAL CARE (Public Limited) - Mechelen

Dossier UNIVERSAL RENAL CARE, printed on 30 October 2026 from databakkes.be/en/0739651526/universal-renal-care. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

UNIVERSAL RENAL CARE from Mechelen, company number BE0739651526, closed financial year 2025 with a result of € -6,046 after tax. For that financial year UNIVERSAL RENAL CARE recorded revenue of € 18,398 and equity of € 9.9 million. Compared with financial year 2024, the result moved from € -8,689 to € -6,046. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.

What it is worth Healthy

€ 9.9 million

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -6,046

▲ 30 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 2,947

▲ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 58,871.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 763,773

▼ 16% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 243,934 Revenue 2022: € 243,934 First fiscal year in the series	€ 311,476 Revenue 2023: € 311,476 ▲ 28% vs 2022 (€ 243,934) Favourable step	€ 79,779 Revenue 2024: € 79,779 ▼ 74% vs 2023 (€ 311,476) Unfavourable step	€ 18,398 Revenue 2025: € 18,398 ▼ 77% vs 2024 (€ 79,779) Unfavourable step	▼ 77%
Gross margin	€ 236,262 Gross margin 2022: € 236,262 First fiscal year in the series	€ 294,694 Gross margin 2023: € 294,694 ▲ 25% vs 2022 (€ 236,262) Favourable step	€ 67,688 Gross margin 2024: € 67,688 ▼ 77% vs 2023 (€ 294,694) Unfavourable step	€ 3,364 Gross margin 2025: € 3,364 ▼ 95% vs 2024 (€ 67,688) Unfavourable step	▼ 95%
Profit after taxes	€ 19,179 Profit after taxes 2022: € 19,179 First fiscal year in the series	€ 57,687 Profit after taxes 2023: € 57,687 ▲ 201% vs 2022 (€ 19,179) Favourable step	€ -8,689 Profit after taxes 2024: € -8,689 ▼ € 66,376 vs 2023 (€ 57,687) Unfavourable step	€ -6,046 Profit after taxes 2025: € -6,046 ▲ € 2,642 vs 2024 (€ -8,689) Favourable step	▲ € 2,642
Equity	€ 1,815,919 Equity 2022: € 1,815,919 First fiscal year in the series	€ 6,873,606 Equity 2023: € 6,873,606 ▲ 279% vs 2022 (€ 1,815,919) Favourable step	€ 9,864,917 Equity 2024: € 9,864,917 ▲ 44% vs 2023 (€ 6,873,606) Favourable step	€ 9,858,871 Equity 2025: € 9,858,871 Unchanged (€ 9,864,917) Unfavourable step
Total debts	€ 700,362 Total debts 2022: € 700,362 First fiscal year in the series	€ 1,345,089 Total debts 2023: € 1,345,089 ▲ 92% vs 2022 (€ 700,362) Unfavourable step	€ 926,853 Total debts 2024: € 926,853 ▼ 31% vs 2023 (€ 1,345,089) Favourable step	€ 1,271,096 Total debts 2025: € 1,271,096 ▲ 37% vs 2024 (€ 926,853) Unfavourable step	▲ 37%
Cash	€ 1,186 Cash 2022: € 1,186 First fiscal year in the series	€ 2,816 Cash 2023: € 2,816 ▲ 137% vs 2022 (€ 1,186) Favourable step	€ 2,920 Cash 2024: € 2,920 ▲ 4% vs 2023 (€ 2,816) Favourable step	€ 2,947 Cash 2025: € 2,947 ▲ 1% vs 2024 (€ 2,920) Favourable step	▲ 1%
Retained profit	€ 15,919 Retained profit 2022: € 15,919 First fiscal year in the series	€ 73,606 Retained profit 2023: € 73,606 ▲ € 57,687 vs 2022 (€ 15,919) Favourable step	€ 64,917 Retained profit 2024: € 64,917 ▼ 12% vs 2023 (€ 73,606) Unfavourable step	€ 58,871 Retained profit 2025: € 58,871 ▼ 9% vs 2024 (€ 64,917) Unfavourable step	▼ 9%
Balance sheet total	€ 2,516,281 Balance sheet total 2022: € 2,516,281 First fiscal year in the series	€ 8,218,695 Balance sheet total 2023: € 8,218,695 ▲ 227% vs 2022 (€ 2,516,281) Unchanged	€ 10,791,770 Balance sheet total 2024: € 10,791,770 ▲ 31% vs 2023 (€ 8,218,695) Unchanged	€ 11,129,968 Balance sheet total 2025: € 11,129,968 ▲ 3% vs 2024 (€ 10,791,770) Unchanged	▲ 3%
Employees (FTE)	0.9 Employees (FTE) 2022: 0.9 First fiscal year in the series	1 Employees (FTE) 2023: 1 ▲ 0.1 vs 2022 (0.9) Unchanged	-	-

Key figures of UNIVERSAL RENAL CARE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to UNIVERSAL RENAL CARE?

What happened at UNIVERSAL RENAL CARE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2031 Serge Ivonne K KEMPS stepped down as director. NBB
2030 Goichi Miyazumi stepped down as director. NBB
Jun 15, 2026 New annual accounts for financial year 2025: loss of € 6,046. Source: NBB ↗
2025 Serge Ivonne K KEMPS became a director. NBB
2025 Goichi Miyazumi became a director. NBB
2025 Hiroki FURUKAWA stepped down as director. NBB
Dec 16, 2019 New establishment in Mechelen. KBO
2019 Hiroki FURUKAWA became a director. NBB

In short

From € 19,179 profit in 2022 to € 6,046 loss in 2025.

Paid € 27,072 in corporate taxes since 2022.

Best year ever: 2023, with € 57,687 profit.

On average € 294,700 of value added per employee in 2023.

Original PDFs at the National Bank ↗

Management

Nipro Medical Europe 100%

UNIVERSAL RENAL CARE

URC SOUTH AFRICA (PTY) LTD 100%

The shares are held by Nipro Medical Europe (100%). It owns 100% of URC SOUTH AFRICA (PTY) LTD itself.

Directors

According to the 2025 annual accounts

Goichi Miyazumi

Director

Also active at: NIPRO MEDICAL EUROPE

since 2025 · until 2030

Hiroki FURUKAWA

Director

since 2019 · until 2025

Serge Ivonne K KEMPS

Managing director

since 2025 · until 2031

Shareholders

Nipro Medical Europe

100%

Participations

URC SOUTH AFRICA (PTY) LTD

100%

Establishments

Establishment units

Physical locations of this company

Registered office

Blokhuisstraat 42

2800 Mechelen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

NIPRO MEDICAL EUROPE same network

€ 385.9 million revenue · 2025

NIPRO EUROPE GROUP COMPANIES

€ 27.5 million revenue · 2025

Nipro PharmaPackaging International

€ 2.2 million revenue · 2025

NIPRO EUROPE HOLDING

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS nipro-group.com

Canonical: https://nipro-group.com/en

About

Technologies

Adobe FontsAvadaCloudflare CDNDrupalGoogle Tag ManagerMatomoOneTrustSlickYouTube EmbedjQueryjsDelivr

Hosting & Email

Email provider

Microsoft 365

Hosting

CLOUDFLARENET - Cloudflare, Inc., US

DNS

Cloudflare DNS

Domain

nipro-group.com

Registered

2008-10-13

Registrar

Hosting Concepts B.V. d/b/a Registrar.eu

Expires

2026-10-13

Website info

HTTPS Ja

Indexable pages 597

Languages EN

Features

Webshop Blog Jobs Client portal Ads Contact page

Security

✓ HTTPS

✗ SPF

✓ DMARC

Network

✓ IPv6

✓ Load balancing

Details

Company number

0739.651.526

VAT number

BE 0739.651.526

Registered office

Blokhuisstraat 42, 2800 Mechelen

Names & denominations

UNIVERSAL RENAL CARE

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

16 December 2019

Peppol

Active · Active since 11 Dec 2025

Contact

nipro-group.com

Activities · NACE

Activiteiten van holdings

Holdings

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

UNIVERSAL RENAL CARE

Warning lights

Financials

What happened to UNIVERSAL RENAL CARE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Network

Details

Frequently asked questions